1. Home
  2. BRNS vs PDSB Comparison

BRNS vs PDSB Comparison

Compare BRNS & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barinthus Biotherapeutics plc

BRNS

Barinthus Biotherapeutics plc

HOLD

Current Price

$0.69

Market Cap

55.9M

Sector

Health Care

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.99

Market Cap

46.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRNS
PDSB
Founded
2016
2005
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
55.9M
46.0M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
BRNS
PDSB
Price
$0.69
$0.99
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$4.00
$9.00
AVG Volume (30 Days)
101.8K
641.8K
Earning Date
11-07-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1766.46
N/A
52 Week Low
$0.64
$0.70
52 Week High
$2.92
$2.20

Technical Indicators

Market Signals
Indicator
BRNS
PDSB
Relative Strength Index (RSI) 33.40 57.25
Support Level $0.66 $0.83
Resistance Level $0.78 $1.13
Average True Range (ATR) 0.07 0.07
MACD 0.02 0.03
Stochastic Oscillator 7.88 63.49

Price Performance

Historical Comparison
BRNS
PDSB

About BRNS Barinthus Biotherapeutics plc

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: